Cargando…
Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
INTRODUCTION: Janus kinases (JAK) inhibitors demonstrated to be effective in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA) but have been associated with serious cardiovascular and serious events. Two systematic reviews and network meta-analyses will be carr...
Autores principales: | Alves, Carlos, Penedones, Ana, Mendes, Diogo, Batel-Marques, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/ https://www.ncbi.nlm.nih.gov/pubmed/33384392 http://dx.doi.org/10.1136/bmjopen-2020-041420 |
Ejemplares similares
-
Biomarkers in Rheumatoid Arthritis
por: Shapiro, Samantha C
Publicado: (2021) -
Topical Janus kinase inhibitors in atopic dermatitis: a safety network meta-analysis
por: Alves, Carlos, et al.
Publicado: (2023) -
Biological tapering and sonographic flare in rheumatoid arthritis
por: Ko, Chi-Hua, et al.
Publicado: (2018) -
Association between baseline vitamin D metabolite levels and long-term cardiovascular events in patients with rheumatoid arthritis from the CIMESTRA trial: protocol for a cohort study with patient-record evaluated outcomes
por: Herly, M, et al.
Publicado: (2017) -
Role of Diet in Influencing Rheumatoid Arthritis Disease Activity
por: Badsha, Humeira
Publicado: (2018)